A proposal by Senator Kent Conrad (D-N.D), to establish member-run healthcare ?co-operatives? is gaining attention.
A proposal by Senator Kent Conrad (D-N.D), to establish member-run healthcare “co-operatives” is gaining attention.
Under Conrad's proposal, co-operatives on state and possibly a national level could gain a federal charter, collect premiums and provide healthcare benefits for its members. Conrad drew a distinction between his proposal and the government-run public health insurance option, reports Dow Jones Newswires.
As CEO of a small business and technology company, Durham, N.C.-based Bloodhound Technologies, Gary Twigg, believes this is a viable option.
“There currently exists a lot of cost shifting between large and small businesses,” Twigg says. “The plan should also help spur efficiencies through competition with existing plans, and has the potential to leverage technology by linking public co-op plans with regional health information networks.”
It is hoped that a bipartisan public plan bill will pass Congress with wide support. Chairman of the Senate Finance Committee Sen. Max Baucus of Montana says President Barack Obama showed interest. Meanwhile, Republican Senator Chuck Grassley of Iowa thought the concept had potential.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Are PBMs Putting GLP-1 Drugs on Their Formularies?
October 11th 2024PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is uneven. What is needed is more data about whether these drugs can lower overall healthcare costs.
Read More